My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2017/1378 of 25 July 2017 renewing the approval of coumatetralyl as an active substance for use in biocidal products of product-type 14 (Text with EEA relevance. )

Commission Implementing Regulation (EU) 2017/1378 of 25 July 2017 renewing the approval of coumatetralyl as an active substance for use in biocidal products of product-type 14 (Text with EEA relevance. )

Implementing Regulation (EU) 2017/1378 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The approval of coumatetralyl as an active substance for use in biocidal products of product-type 14 is renewed, subject to the specifications and conditions set out in the Annex.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Expiry date of approval Product type Specific conditions Coumatetralyl IUPAC Name: 4-hydroxy-3-(1, 2, 3, 4-tetrahydro-1-naphthyl)coumarin EC No: 227-424-0 CAS No: 5836-29-3 980 g/kg 30 June 2024 14 Coumatetralyl is considered a candidate for substitution in accordance with points (a) and (e) of Article 10(1) of Regulation (EU) No 528/2012. The authorisations of biocidal products are subject to the following general conditions: (1) The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance. In addition, pursuant to point 10 of Annex VI to Regulation (EU) No 528/2012, the product assessment shall include an evaluation as to whether the conditions of Article 5(2) of Regulation (EU) No 528/2012 can be satisfied. (2) Products shall only be authorised for use in Member States where at least one of the conditions set out in Article 5(2) of Regulation (EU) No 528/2012 is satisfied. (3) The nominal concentration of coumatetralyl in the products shall not exceed 375 mg/kg in products other than contact formulations and shall not exceed 4 000 mg/kg in contact formulations. (4) Products shall contain an aversive agent and a dye. (5) Products shall not be authorised in the form of tracking powder. (6) Products in the form of contact formulations, other than tracking powder, shall only be authorised for use by trained professionals indoors in places not accessible to children or non-target animals. (7) Products shall not be authorised for use in permanent or pulse baiting treatments. (8) Only ready-to-use products shall be authorised. (9) Primary as well as secondary exposure of humans, non-target animals and the environment are minimised, by considering and applying all appropriate and available risk mitigation measures. These include for example the restriction to professional or trained professional use when possible and setting additional specific conditions per user category. (10) Dead bodies and uneaten bait shall be disposed of in accordance with local requirements. The method of disposal shall be described specifically in the summary of the product characteristics of the national authorisation and be reflected on the product label. In addition to the general conditions, the authorisations of biocidal products to be used by the general public are subject to the following conditions: (1) Products shall only be authorised for use in tamper-resistant bait stations. (2) Products shall only be supplied with a maximum quantity of bait per pack of: (a) for products against mice only: (i) For grain, pellet or paste baits: 250 g; (ii) For wax block baits: 500 g; (b) for products against rats only, or mice and rats: (i) for grain, pellet or paste baits: 750 g; (ii) for wax block baits: 1 500 g. (3) Products against Rattus norvegicus and Rattus rattus shall only be authorised for use indoors or in and around buildings. (4) Products against Mus musculus shall only be authorised for use indoors. (5) Persons making products available on the market shall ensure that the products are accompanied by information on the risks associated with anticoagulant rodenticides in general, measures to limit their use to the minimum necessary and appropriate precautionary steps to be taken. (6) Products in the form of loose bait formulations, such as grain or pellets, shall only be authorised in formulations that are supplied in sachets or other packaging to reduce exposure to humans and the environment. In addition to the general conditions, the authorisations of biocidal products to be used by professionals are subject to the following conditions: (1) Products shall not be authorised for use in sewers, open area or waste dumps. (2) Products shall only be authorised for use in tamper-resistant bait stations. (3) Persons making products for professional users available on the market shall make sure that these products are not supplied to the general public. In addition to the general conditions, the authorisations of biocidal products to be used by trained professionals are subject to the following conditions: (1) Products may be authorised for use in sewers, open area or waste dumps. (2) Products may be authorised for use in covered and protected bait points as long as they provide the same level of protection for non-target species and humans as tamper-resistant bait stations. (3) Persons making products for trained professional users available on the market shall make sure that the products are not supplied to other persons than trained professionals. ( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

Other acts of the same type
Commission Implementing Regulation (EU) 2026/2046 of 14 September 2026 amending Implementing Regulation (EU) 2022/964 as regards administrative and minor changes to the Union authorisation for the biocidal product family SOPUROXIDCommission Implementing Regulation (EU) 2026/2047 of 14 September 2026 extending the retrospective Union surveillance of imports of renewable ethanol for fuelCommission Implementing Regulation (EU) 2026/2049 of 14 September 2026 making imports of primary cells and primary batteries of alkaline manganese dioxide originating in People’s Republic of China subject to registration with a view to allowing the levy of anti-dumping duties on the imports subject to registrationCommission Implementing Regulation (EU) 2026/2105 of 14 September 2026 on the registration of the geographical indication Nivegy-völgy / Nivegy-völgyi (PDO) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/2106 of 14 September 2026 on the approval of a Union amendment to the product specification of the protected designation of origin Segarcea pursuant to of Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/2031 of 11 September 2026 amending Implementing Regulation (EU) 2017/373 as regards requirements for activities contracted by service providersCommission Implementing Regulation (EU) 2026/2041 of 11 September 2026 laying down rules for the application of Directive 2009/138/EC of the European Parliament and of the Council as regards technical information for the calculation of technical provisions and basic own funds for reporting with reference dates from 30 June 2026 until 29 September 2026Commission Implementing Regulation (EU) 2026/2042 of 11 September 2026 granting a Union authorisation for the biocidal product OXTERIL® 350 VHP in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/2044 of 11 September 2026 amending Implementing Regulation (EU) 2024/1767 as regards administrative changes to the Union authorisation of the biocidal product family Sure Lactic FamilyCommission Implementing Regulation (EU) 2026/2050 of 11 September 2026 granting a Union authorisation for the biocidal product family Hydrogen peroxide biocidal product family in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/2051 of 11 September 2026 granting a Union authorisation for the biocidal product family Hydrogen peroxide product family P & G in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2026/2054 of 11 September 2026 granting a Union authorisation for the biocidal product family Hydrogen peroxides biocides family in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next